This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 3 EPO patents. Top assignees: Ospedale San Raffaele S.r.l., Sangamo Biosciences, Inc., Sangamo Therapeutics, Inc.. Active years: 2015-2017.
Company Filing History:
1 out of 55 
1 out of 160 
1 out of 153 
Years Active: 2015-2017
Title: Shuyuan Yao: Innovator in Stem Cell Integration
Introduction
Shuyuan Yao is a prominent inventor based in San Diego, CA (US). He has made significant contributions to the field of stem cell research, particularly in the area of targeted integration techniques. With a total of 2 patents, Yao's work is paving the way for advancements in genetic engineering and regenerative medicine.
Latest Patents
Yao's latest patents focus on innovative methods for targeted integration into stem cells. The first patent discloses methods and compositions for the targeted integration of sequences of interest, such as lineage-specific or cell fate reporter constructs, into stem cells. The second patent outlines methods and compositions for targeted integration using zinc finger nucleases (ZFNs), which include a zinc finger protein and a cleavage domain or cleavage half-domain, along with integrase-defective lentiviral donor constructs.
Career Highlights
Throughout his career, Shuyuan Yao has worked with notable companies in the biotechnology sector. He has been associated with Sangamo Biosciences, Inc. and Ospedale San Raffaele S.r.l., where he has contributed to groundbreaking research and development in genetic engineering.
Collaborations
Yao has collaborated with esteemed colleagues, including Michael C. Holmes and Luigi Naldini. These partnerships have further enhanced his research and innovation in the field of stem cell technology.
Conclusion
Shuyuan Yao's contributions to stem cell integration and genetic engineering are noteworthy. His innovative patents and collaborations reflect his commitment to advancing scientific knowledge and technology in this vital area of research.